These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4300395)

  • 21. [Adreno-sympathetic activity and congestive cardiac insufficiency].
    Valori C; Renzini V; Brunori CA; Porcellati C; Corea L; Petz E; Muiesan G
    Cuore Circ; 1968 Dec; 52(6):285-306. PubMed ID: 5710403
    [No Abstract]   [Full Text] [Related]  

  • 22. Adrenergic nervous system in heart failure.
    Esler M; Kaye D; Lambert G; Esler D; Jennings G
    Am J Cardiol; 1997 Dec; 80(11A):7L-14L. PubMed ID: 9412538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of colchicine and cytochalasin B on the release of 3 H-norepinephrine from guinea-pig atria evoked by high potassium, nicotine and tyramine.
    Sorimachi M; Oesch F; Thoenen H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 276(1):1-12. PubMed ID: 4347992
    [No Abstract]   [Full Text] [Related]  

  • 24. Normalization of total body and regional sympathetic hyperactivity in heart failure after heart transplantation.
    Rundqvist B; Elam M; Eisenhofer G; Friberg P
    J Heart Lung Transplant; 1996 May; 15(5):516-26. PubMed ID: 8771507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effect of nicotine on plasma norepinephrine levels in normal humans and in patients with congestive heart failure.
    Goldsmith SR; Dodge-Brown D; Katz A; Crooks PA
    Am J Cardiol; 1989 Jan; 63(1):122-3. PubMed ID: 2909144
    [No Abstract]   [Full Text] [Related]  

  • 26. Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity.
    Azevedo ER; Kubo T; Mak S; Al-Hesayen A; Schofield A; Allan R; Kelly S; Newton GE; Floras JS; Parker JD
    Circulation; 2001 Oct; 104(18):2194-9. PubMed ID: 11684630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac positron emission tomography imaging with [11C]hydroxyephedrine, a specific tracer for sympathetic nerve endings, and its functional correlates in congestive heart failure.
    Vesalainen RK; Pietilä M; Tahvanainen KU; Jartti T; Teräs M; Någren K; Lehikoinen P; Huupponen R; Ukkonen H; Saraste M; Knuuti J; Voipio-Pulkki LM
    Am J Cardiol; 1999 Sep; 84(5):568-74. PubMed ID: 10482157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure.
    Newton GE; Parker JD
    Circulation; 1996 Aug; 94(3):353-8. PubMed ID: 8759076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure.
    Rundqvist B; Elam M; Bergmann-Sverrisdottir Y; Eisenhofer G; Friberg P
    Circulation; 1997 Jan; 95(1):169-75. PubMed ID: 8994433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of norepinephrine biosynthesis.
    Weiner N
    Annu Rev Pharmacol; 1970; 10():273-90. PubMed ID: 4315686
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse consequences of high sympathetic nervous activity in the failing human heart.
    Kaye DM; Lefkovits J; Jennings GL; Bergin P; Broughton A; Esler MD
    J Am Coll Cardiol; 1995 Nov; 26(5):1257-63. PubMed ID: 7594040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity.
    Mansfield D; Kaye DM; Brunner La Rocca H; Solin P; Esler MD; Naughton MT
    Circulation; 2003 Mar; 107(10):1396-400. PubMed ID: 12642360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.
    Hasking GJ; Esler MD; Jennings GL; Burton D; Johns JA; Korner PI
    Circulation; 1986 Apr; 73(4):615-21. PubMed ID: 3948363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure.
    Kingwell BA; Thompson JM; Kaye DM; McPherson GA; Jennings GL; Esler MD
    Circulation; 1994 Jul; 90(1):234-40. PubMed ID: 8026003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyramine-induced endogenous noradrenaline efflux from in situ cardiac sympathetic nerve ending in cats.
    Takauchi Y; Yamazaki T; Akiyama T
    Acta Physiol Scand; 2000 Feb; 168(2):287-93. PubMed ID: 10712566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STUDIES ON THE FUNCTION OF THE ADRENERGIC NERVE ENDINGS IN THE HEART.
    BRAUNWALD E; CHIDSEY CA; HARRISON DC; GAFFNEY TE; KAHLER RL
    Circulation; 1963 Nov; 28():958-69. PubMed ID: 14079202
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic norepinephrine infusion and adrenergic function of hypertrophied hearts.
    Siri FM
    Am J Physiol; 1985 Apr; 248(4 Pt 2):H485-92. PubMed ID: 3157327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of chronic pretreatment with small doses of reserpine upon adrenergic nerve function.
    Antonaccio MJ; Smith CB
    J Pharmacol Exp Ther; 1974 Mar; 188(3):654-67. PubMed ID: 4816332
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of orthotopic heart transplantation on sympathetic control mechanisms in congestive heart failure.
    Levine TB; Olivari MT; Cohn JN
    Am J Cardiol; 1986 Nov; 58(10):1035-40. PubMed ID: 3535471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered cardiac adrenergic neurotransmission in streptozotocin-induced diabetic rats.
    Gando S; Hattori Y; Kanno M
    Br J Pharmacol; 1993 Aug; 109(4):1276-81. PubMed ID: 8401939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.